Clinical Trials in Texas

Showing 10721-10740 of 12,973 trials

Re-Engineering Systems for the Primary Care Treatment for PTSD

NCT00373698

The study is an evaluation of a systemic intervention to enhance the delivery of care according to practice guidelines for posttraumatic stress disorder (PTSD). The immediate objectives are to (1) implement three component model (3CM) in VA primary care clinics; and (2) evaluate the effects of 3CM on clinician behavior and patient outcomes. The long-term objectives are to generate information to support implementation research on the RESPECT model for treating PTSD in primary care and ultimately, the implementation of the model in VHA to provide care to veterans with PTSD.

Stress Disorders, PosttraumaticDepression

US Department of Veterans Affairs195 participantsStarted Mar 2008

Dallas, Texas, United States • Temple, Texas, United States • Waco, Texas, United States +1 more locations

COMPLETEDPhase 2/330 miles

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

NCT00734474

This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type 2 diabetes mellitus on Metformin.

Diabetes Mellitus, Type 2

Eli Lilly and Company1,202 participantsStarted Aug 2008

Peoria, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +96 more locations

Re-Engineering Systems for the Primary Care Treatment for PTSD

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Find Trials by Condition in Texas

CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness

Pharmacokinetic Study of MTC896 Gel in Subjects With Acne

Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

CSP #512 - Options in Management With Anti-Retrovirals

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes

Effect of Teriparatide on Hip Fracture Healing

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)